Peptide Synthesis

Peptide Sequence: human EP2 receptor amino acids 335-358 (SLRTQDATQTSCSTQSDASKQADL) To be used in conjunction with Cayman&rsquos EP2 receptor polyclonal antibody (Catalog No. 101750) to block protein-antibody complex formation during immunochemical

Immunogen 14 amino acids near the amino terminus of human EphA10. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 19 amino acids near the carboxy terminus of human ERAP. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 19 amino acids near the amino terminus of human ESRRB. Application Used as a blocking peptide in immunoblotting applications.

Application Ethyl dichlorophosphite was used in the synthesis of peptide derivatives .

Immunogen 14 amino acids near the center of human EVER2. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 14 amino acids near the amino terminus of human EVER2. Application Used as a blocking peptide in immunoblotting applications.

Exendin-4: Exendin-4 is a novel 39-amino acid peptide isolated from the venom of the Gila monster Heloderma suspectum. It shares 53% sequence homology with GLP-17-36amide and interacts with the same membrane receptor.

Exendin-4: Exendin-4 is a novel 39-amino acid peptide isolated from the venom of the Gila monster Heloderma suspectum. It shares 53% sequence homology with GLP-17-36amide and interacts with the same membrane receptor.

Exendin-4: Exendin-4 is a novel 39-amino acid peptide isolated from the venom of the Gila monster Heloderma suspectum. It shares 53% sequence homology with GLP-17-36amide and interacts with the same membrane receptor.

Exendin-4 is a novel 39-amino acid peptide isolated from the venom of the Gila monster Heloderma suspectum. It shares 53% sequence homology with GLP-17-36amide and interacts with the same membrane receptor.

Exendin-4 is a novel 39-amino acid peptide isolated from the venom of the Gila monster Heloderma suspectum. It shares 53% sequence homology with GLP-17-36amide and interacts with the same membrane receptor.